Survodutide hits where other weight loss drugs miss
Phase 3 data from the SYNCHRONIZE-1 trial shows the experimental drug reducing visceral and liver fat while preserving lean muscle mass in adults with obesity. Most weight loss medications work by suppressing appetite. Survodutide does that too, but the experimental drug developed by Boehringer Ingelheim is drawing attention for what it […]